Arcutis Biotherapeutics ARQT Stock
Arcutis Biotherapeutics Price Chart
Arcutis Biotherapeutics ARQT Financial and Trading Overview
| Arcutis Biotherapeutics stock price | 8.59 USD |
| Previous Close | 10.69 USD |
| Open | 10.57 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 1300 |
| Day's Range | 10.1 - 10.76 USD |
| 52 Week Range | 7.25 - 27.4 USD |
| Volume | 1.08M USD |
| Avg. Volume | 1.22M USD |
| Market Cap | 627.74M USD |
| Beta (5Y Monthly) | 0.481963 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.79 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 44.78 USD |
ARQT Valuation Measures
| Enterprise Value | 527.58M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.7253335 |
| PEG Ratio (5 yr expected) | -0.23 |
| Price/Sales (ttm) | 97.067566 |
| Price/Book (mrq) | 4.4883623 |
| Enterprise Value/Revenue | 81.58 |
| Enterprise Value/EBITDA | -1.68 |
Trading Information
Arcutis Biotherapeutics Stock Price History
| Beta (5Y Monthly) | 0.481963 |
| 52-Week Change | -51.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.4 USD |
| 52 Week Low | 7.25 USD |
| 50-Day Moving Average | 11.52 USD |
| 200-Day Moving Average | 15.34 USD |
ARQT Share Statistics
| Avg. Volume (3 month) | 1.22M USD |
| Avg. Daily Volume (10-Days) | 1.22M USD |
| Shares Outstanding | 61.42M |
| Float | 47.34M |
| Short Ratio | 8.77 |
| % Held by Insiders | 3.02% |
| % Held by Institutions | 110.35% |
| Shares Short | 13.04M |
| Short % of Float | 31.23% |
| Short % of Shares Outstanding | 21.24% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4874.96% |
| Gross Margin | 76.23% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.99% |
| Return on Equity (ttm) | -166.31% |
Income Statement
| Revenue (ttm) | 6.47M USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 2.93M USD |
| EBITDA | -314116992 USD |
| Net Income Avi to Common (ttm) | -327233984 USD |
| Diluted EPS (ttm) | -5.57 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 332.4M USD |
| Total Cash Per Share (mrq) | 5.41 USD |
| Total Debt (mrq) | 203.38M USD |
| Total Debt/Equity (mrq) | 145.55 USD |
| Current Ratio (mrq) | 9.93 |
| Book Value Per Share (mrq) | 2.277 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -281084000 USD |
| Levered Free Cash Flow (ttm) | -212602000 USD |
Profile of Arcutis Biotherapeutics
| Country | United States |
| State | CA |
| City | Westlake Village |
| Address | 3027 Townsgate Road |
| ZIP | 91361 |
| Phone | 805 418 5006 |
| Website | https://www.arcutis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 268 |
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical formulation of ivarmacitinib designed to reach deeper into the skin in order to treat alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Q&A For Arcutis Biotherapeutics Stock
What is a current ARQT stock price?
Arcutis Biotherapeutics ARQT stock price today per share is 8.59 USD.
How to purchase Arcutis Biotherapeutics stock?
You can buy ARQT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Arcutis Biotherapeutics?
The stock symbol or ticker of Arcutis Biotherapeutics is ARQT.
Which industry does the Arcutis Biotherapeutics company belong to?
The Arcutis Biotherapeutics industry is Biotechnology.
How many shares does Arcutis Biotherapeutics have in circulation?
The max supply of Arcutis Biotherapeutics shares is 115.76M.
What is Arcutis Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Arcutis Biotherapeutics PE Ratio is now.
What was Arcutis Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Arcutis Biotherapeutics EPS is -2.79 USD over the trailing 12 months.
Which sector does the Arcutis Biotherapeutics company belong to?
The Arcutis Biotherapeutics sector is Healthcare.
Arcutis Biotherapeutics ARQT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16920.58 USD — |
-0.58
|
6.33B USD — | 16873.97 USD — | 16989.6 USD — | — - | 6.33B USD — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2092.23 USD — |
-1.44
|
— — | 2090.93 USD — | 2099.3 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8246.62 USD — |
-0.57
|
— — | 8223.97 USD — | 8280.54 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4311.81 USD — |
-1.19
|
— — | 4286.36 USD — | 4323.39 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 967.78 USD — |
-1.12
|
— — | 964.91 USD — | 969.79 USD — | — - | — — |
- {{ link.label }} {{link}}